332 related articles for article (PubMed ID: 24637012)
1. Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists.
Karaki S; Becamel C; Murat S; Mannoury la Cour C; Millan MJ; Prézeau L; Bockaert J; Marin P; Vandermoere F
Mol Cell Proteomics; 2014 May; 13(5):1273-85. PubMed ID: 24637012
[TBL] [Abstract][Full Text] [Related]
2. Differential signaling signatures evoked by DOI versus lisuride stimulation of the 5-HT
Banerjee AA; Vaidya VA
Biochem Biophys Res Commun; 2020 Oct; 531(4):609-614. PubMed ID: 32814630
[TBL] [Abstract][Full Text] [Related]
3. Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.
González-Maeso J; Weisstaub NV; Zhou M; Chan P; Ivic L; Ang R; Lira A; Bradley-Moore M; Ge Y; Zhou Q; Sealfon SC; Gingrich JA
Neuron; 2007 Feb; 53(3):439-52. PubMed ID: 17270739
[TBL] [Abstract][Full Text] [Related]
4. G
Liu X; Zhu H; Gao H; Tian X; Tan B; Su R
Biochem Biophys Res Commun; 2022 Apr; 598():20-25. PubMed ID: 35149433
[TBL] [Abstract][Full Text] [Related]
5. Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes.
Borroto-Escuela DO; Romero-Fernandez W; Narvaez M; Oflijan J; Agnati LF; Fuxe K
Biochem Biophys Res Commun; 2014 Jan; 443(1):278-84. PubMed ID: 24309097
[TBL] [Abstract][Full Text] [Related]
6. LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor.
Halberstadt AL; Geyer MA
Psychopharmacology (Berl); 2010 Feb; 208(2):179-89. PubMed ID: 19937319
[TBL] [Abstract][Full Text] [Related]
7. 5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice.
Halberstadt AL; van der Heijden I; Ruderman MA; Risbrough VB; Gingrich JA; Geyer MA; Powell SB
Neuropsychopharmacology; 2009 Jul; 34(8):1958-67. PubMed ID: 19322172
[TBL] [Abstract][Full Text] [Related]
8. Phospholipase C mediates (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-, but not lysergic acid diethylamide (LSD)-elicited head bobs in rabbit medial prefrontal cortex.
Schindler EA; Harvey JA; Aloyo VJ
Brain Res; 2013 Jan; 1491():98-108. PubMed ID: 23123701
[TBL] [Abstract][Full Text] [Related]
9. Tolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT
de la Fuente Revenga M; Jaster AM; McGinn J; Silva G; Saha S; González-Maeso J
ACS Chem Neurosci; 2022 Aug; 13(16):2436-2448. PubMed ID: 35900876
[TBL] [Abstract][Full Text] [Related]
10. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
Marek GJ; Aghajanian GK
J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
[TBL] [Abstract][Full Text] [Related]
11. Functional selectivity in serotonin receptor 2A (5-HT2A) endocytosis, recycling, and phosphorylation.
Raote I; Bhattacharyya S; Panicker MM
Mol Pharmacol; 2013 Jan; 83(1):42-50. PubMed ID: 23034456
[TBL] [Abstract][Full Text] [Related]
12. The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen.
Canal CE; Olaghere da Silva UB; Gresch PJ; Watt EE; Sanders-Bush E; Airey DC
Psychopharmacology (Berl); 2010 Apr; 209(2):163-74. PubMed ID: 20165943
[TBL] [Abstract][Full Text] [Related]
13. Interaction of 5-HT2A and 5-HT2C receptors in R(-)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice.
Fantegrossi WE; Simoneau J; Cohen MS; Zimmerman SM; Henson CM; Rice KC; Woods JH
J Pharmacol Exp Ther; 2010 Dec; 335(3):728-34. PubMed ID: 20858706
[TBL] [Abstract][Full Text] [Related]
14. Structure-based discovery of nonhallucinogenic psychedelic analogs.
Cao D; Yu J; Wang H; Luo Z; Liu X; He L; Qi J; Fan L; Tang L; Chen Z; Li J; Cheng J; Wang S
Science; 2022 Jan; 375(6579):403-411. PubMed ID: 35084960
[TBL] [Abstract][Full Text] [Related]
15. Acute serotonin 2A receptor activation impairs behavioral flexibility in mice.
Amodeo DA; Hassan O; Klein L; Halberstadt AL; Powell SB
Behav Brain Res; 2020 Oct; 395():112861. PubMed ID: 32814148
[TBL] [Abstract][Full Text] [Related]
16. Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors.
Moya PR; Berg KA; Gutiérrez-Hernandez MA; Sáez-Briones P; Reyes-Parada M; Cassels BK; Clarke WP
J Pharmacol Exp Ther; 2007 Jun; 321(3):1054-61. PubMed ID: 17337633
[TBL] [Abstract][Full Text] [Related]
17. Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD).
Schindler EA; Dave KD; Smolock EM; Aloyo VJ; Harvey JA
Pharmacol Biochem Behav; 2012 Mar; 101(1):69-76. PubMed ID: 22197710
[TBL] [Abstract][Full Text] [Related]
18. Hallucinogens and Serotonin 5-HT
López-Giménez JF; González-Maeso J
Curr Top Behav Neurosci; 2018; 36():45-73. PubMed ID: 28677096
[TBL] [Abstract][Full Text] [Related]
19. Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex.
González-Maeso J; Yuen T; Ebersole BJ; Wurmbach E; Lira A; Zhou M; Weisstaub N; Hen R; Gingrich JA; Sealfon SC
J Neurosci; 2003 Oct; 23(26):8836-43. PubMed ID: 14523084
[TBL] [Abstract][Full Text] [Related]
20. Agonist-induced serotonin 2A receptor desensitization in the rat frontal cortex and hypothalamus.
Damjanoska KJ; Heidenreich BA; Kindel GH; D'Souza DN; Zhang Y; Garcia F; Battaglia G; Wolf WA; Van de Kar LD; Muma NA
J Pharmacol Exp Ther; 2004 Jun; 309(3):1043-50. PubMed ID: 14976228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
